Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Heparanase expression correlates with poor survival in oral mucosal melanoma.

Wang X, Wen W, Wu H, Chen Y, Ren G, Guo W.

Med Oncol. 2013;30(3):633. doi: 10.1007/s12032-013-0633-5. Epub 2013 Jun 21.

PMID:
23794232
[PubMed - indexed for MEDLINE]
2.

Tumor size and depth in primary malignant melanoma in the oral cavity influences survival.

Mücke T, Hölzle F, Kesting MR, Loeffelbein DJ, Robitzky LK, Hohlweg-Majert B, Tannapfel A, Wolff KD.

J Oral Maxillofac Surg. 2009 Jul;67(7):1409-15. doi: 10.1016/j.joms.2008.12.021.

PMID:
19531410
[PubMed - indexed for MEDLINE]
3.

Treatment and prognosis of oral mucosal melanoma.

Sun CZ, Chen YF, Jiang YE, Hu ZD, Yang AK, Song M.

Oral Oncol. 2012 Jul;48(7):647-52. doi: 10.1016/j.oraloncology.2012.01.019. Epub 2012 Feb 19.

PMID:
22349277
[PubMed - indexed for MEDLINE]
4.

Heparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma.

Rivera RS, Nagatsuka H, Siar CH, Gunduz M, Tsujigiwa H, Han PP, Katase N, Tamamura R, Ng KH, Naomoto Y, Nakajima M, Nagai N.

Oncol Rep. 2008 Mar;19(3):657-61.

PMID:
18288398
[PubMed - indexed for MEDLINE]
5.

Primary oral mucosal melanoma: advocate a wait-and-see policy in the clinically N0 patient.

Wang X, Wu HM, Ren GX, Tang J, Guo W.

J Oral Maxillofac Surg. 2012 May;70(5):1192-8. doi: 10.1016/j.joms.2011.03.036. Epub 2011 Jul 23.

PMID:
21783300
[PubMed - indexed for MEDLINE]
6.

Prognostic value of heparanase expression and cellular localization in oral cancer.

Leiser Y, Abu-El-Naaj I, Sabo E, Akrish S, Ilan N, Ben-Izhak O, Peled M, Vlodavsky I.

Head Neck. 2011 Jun;33(6):871-7. doi: 10.1002/hed.21545. Epub 2010 Sep 21.

PMID:
20859999
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival.

Ben-Izhak O, Kaplan-Cohen V, Ilan N, Gan S, Vlodavsky I, Nagler R.

Neoplasia. 2006 Oct;8(10):879-84.

PMID:
17032504
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.

Huang GL, Li BK, Zhang MY, Wei RR, Yuan YF, Shi M, Chen XQ, Huang L, Zhang HZ, Liu W, Huang BJ, Li H, Zheng XF, Luo XR, Wang HY.

PLoS One. 2012;7(8):e44061. doi: 10.1371/journal.pone.0044061. Epub 2012 Aug 31.

PMID:
22952874
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

[Fourteen cases of mucosal melanomas of the oral cavity].

Notani K, Shindo M, Mizukoshi T, Yamashita T, Totsuka Y, Fukuda H, Amemiya A.

Gan No Rinsho. 1987 Feb;33(2):129-37. Japanese.

PMID:
3560447
[PubMed - indexed for MEDLINE]
10.

[Analysis of prognostic factors of primary mucosal melanoma in nasal and oral cavity].

Lin J, Li C, Wu G, Zeng Z.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Jan;26(2):49-52. Chinese.

PMID:
22500456
[PubMed - indexed for MEDLINE]
11.

[A clinical and pathological study on primary oral mucosal malignant melanoma].

Chen Y, He Z, Wu L.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2003 Feb;21(1):31-3. Chinese.

PMID:
12674617
[PubMed - indexed for MEDLINE]
Free Article
12.

Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma.

Yang X, Ren GX, Zhang CP, Zhou GY, Hu YJ, Yang WJ, Guo W, Li J, Zhong LP.

BMC Cancer. 2010 Nov 11;10:623. doi: 10.1186/1471-2407-10-623.

PMID:
21070637
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Heparanase and cyclooxygenase-2 gene and protein expressions during progression of oral epithelial dysplasia to carcinoma.

Nagatsuka H, Siar CH, Tsujigiwa H, Naomoto Y, Han PP, Gunduz M, Sugahara T, Sasaki A, Nakajima M.

Ann Diagn Pathol. 2012 Oct;16(5):354-61. doi: 10.1016/j.anndiagpath.2012.02.004. Epub 2012 May 8.

PMID:
22575501
[PubMed - indexed for MEDLINE]
14.

Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival.

Bar-Sela G, Kaplan-Cohen V, Ilan N, Vlodavsky I, Ben-Izhak O.

Histopathology. 2006 Aug;49(2):188-93.

PMID:
16879396
[PubMed - indexed for MEDLINE]
15.

NRAS and BRAF mutation frequency in primary oral mucosal melanoma.

Buery RR, Siar CH, Katase N, Gunduz M, Lefeuvre M, Fujii M, Inoue M, Setsu K, Nagatsuka H.

Oncol Rep. 2011 Oct;26(4):783-7. doi: 10.3892/or.2011.1385. Epub 2011 Jul 11.

PMID:
21750866
[PubMed - indexed for MEDLINE]
16.

Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.

Aucoin R, Reiland J, Roy M, Marchetti D.

J Cell Biochem. 2004 Oct 1;93(2):215-23.

PMID:
15368349
[PubMed - indexed for MEDLINE]
17.

Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study.

Lee SW, Kim SG, Park YW, Kweon H, Kim JY, Rotaru H.

Tumour Biol. 2013 Jun;34(3):1595-603. doi: 10.1007/s13277-013-0690-6. Epub 2013 Feb 15.

PMID:
23412976
[PubMed - indexed for MEDLINE]
18.

Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.

Yue Z, Song Y, Wang Z, Luo Y, Jiang L, Xing L, Xu H, Zhang X.

J Surg Oncol. 2010 Jul 1;102(1):68-72. doi: 10.1002/jso.21584.

PMID:
20578081
[PubMed - indexed for MEDLINE]
19.

Heparanase up-regulation in tongue cancer: tissue and saliva analysis.

Nagler R, Ben-Izhak O, Cohen-Kaplan V, Shafat I, Vlodavsky I, Akrish S, Ilan N.

Cancer. 2007 Dec 15;110(12):2732-9.

PMID:
17955520
[PubMed - indexed for MEDLINE]
Free Article
20.

Oral malignant melanoma: the amsterdam experience.

Meleti M, Leemans CR, Mooi WJ, van der Waal I.

J Oral Maxillofac Surg. 2007 Nov;65(11):2181-6.

PMID:
17954312
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk